NeuroStar TMS Therapy is a new, noninvasive treatment option for patients with depression who have not achieved satisfactory results from previous antidepressant treatment. TMS (transcranial magnetic stimulation) uses magnetic field stimulation to treat the symptoms of depression and has been approved by the US Food and Drug Administration (FDA).

Medical Director

Dr. Edgar Castillo-Armas obtained his medical degree from the University of San Carlos, School of Medicine in Guatemala. He completed General Psychiatry Training at UC San Francisco/Fresno Medical Education Program. He also finished a two year fellowship in Child and Adolescent Psychiatry at Harbor/UCLA Medical Center in Torrance, California. After completing his training, Dr.Castillo-Armas was in private practice in Fresno for over ten years. He served as Chief Medical Officer/Healthcare Manager at the California Substance Abuse Treatment Facility/State Prison in Corcoran for 5 years. He also served as Chief Child Psychiatrist at the Department of Children and Family Services of Fresno County. Dr. Castillo-Armas has lectured extensively in California and has participated in psychiatric international forums dealing with Mood Disorders, Substance Abuse, Autistic Spectrum Disorders and Suicide Epidemiology.



Michelle Mott came to Central California TMS Center since its opening in March 2010. Previously, she had worked in the mental healthcare field since 2007. Michelle obtained her Associates of Arts Degree at Fresno City College. There she completed numerous courses in Administrative Medical Assisting. She was awarded Top Student Award in Today's Receptionist and Medical Terminology. Michelle has also completed two years of Spanish in college as well as earned a course completion certificate for Conversational Spanish. For this course she was nominated for the AGS Student Achievement Award.

In February 2011, she successfully completed the Neurostar University Clinical Training Program for Transcranial Magnetic Stimulation therapy. At Central California TMS Center, Michelle has observed the improvements of how this non-drug therapy with NeuroStar TMS has not only reduced the symptomatic suffering of patients, but lessens the disability of depression improving their outlook to return to functioning effectively at home, in the workplace, and in the community.

Michelle’s own experience as a TMS Coordinator: “It is truly amazing to see a severely depressed patient recover in just a few weeks from such a debilitating disease.”